FDA Approves Belviq Weight Loss Pill

Comments:  | Leave A Comment

via BBC News

US health regulators have approved a weight-loss pill for the first time in 13 years.

Belviq, made by Arena Pharmaceutical, can be used by obese or overweight adults with at least one condition.

The drug achieved only modest results in clinical studies, helping people lose on average about 5% of their body weight.

Belviq was rejected in 2010 because of concerns over tumors that developed in animals tested with the drug.

After San Diego-based Arena resubmitted its application with more data, the US Food and Drug Administration (FDA) found little risk of tumors in humans using the drug.

The medication is expected to launch in 2013.

Belviq is designed to block appetite signals in the brain, making patients feel fuller with smaller amounts of food.

It has been approved for use in obese adults with a body mass index of 30 or greater.

The drug can also be used by overweight adults with a BMI of 27 or greater if they have at least one other condition such as high blood pressure, type 2 diabetes or high cholesterol.

The FDA warned that Belviq is not for women who are pregnant or nursing.

Read Full Story

Article courtesy bbc.co.uk

Join the Conversation! Share and Discuss!

Tags: » » »

  • More Related Content

Comments

blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 349 other followers